A new prospective U.S. Cohort set within the health care system institutions to study cancer

Active Awarded Last action

Contract number
75N91018D00021
Awardee
Awarding agency
Task orders
8 $33,006,267 obligated

Award facts

Opportunity
  • N02CP7100958 Solicitation number
Combined order value
  • $40,031,858 Current, with exercised options
  • $43,983,746 Potential, with all options
Last date to order 84% complete
IDV ceiling 22% used
$150,000,000.00
Award type
Multiple award
Who can order
Only the awarding agency
Set-aside
No set-aside
Competition
Full and Open Competition · 4 offers Negotiated Proposal / Quote
Pricing
Order Dependent (IDV only)

Award details come from SAM.gov/FPDS.

About this IDV

The National Cancer Institute awarded a multiple-award indefinite-delivery contract to Kaiser Foundation Hospitals for $150 million on June 4, 2018, with ultimate completion on June 3, 2028, to establish a new prospective U.S. cohort within health care system institutions to study cancer.

Kaiser Foundation Hospitals operates through its Kaiser Foundation Research Institute division and does business as Kaiser Permanente, a non-profit integrated healthcare system. The contract carries no set-aside designation and is one of multiple awards under this vehicle.

Place of performance spans multiple U.S. locations including Oakland, California; Denver, Colorado; Chicago, Illinois; Atlanta, Georgia; and Portland, Oregon, reflecting the nationwide scope of cohort recruitment and study infrastructure development.

The IDIQ funds cancer research infrastructure, participant recruitment, advisory board support, and study planning across Kaiser Permanente's integrated health system and electronic health records encompassing diverse patient populations. Recent task orders issued under this contract include CONNECT Task Order 8, a $20.1 million cost-no-fee delivery order awarded September 20, 2024, for cohort recruitment and management performed in Denver, Colorado, with completion by September 19, 2027; Study Preparation and Launch, a $20.6 million cost-no-fee order issued July 25, 2020, also performed in Denver with completion August 9, 2025; a $1.48 million cost-no-fee delivery order awarded April 1, 2022, to sustain the Participant Advisory Board for the Connect for Cancer Prevention Study in Chicago, Illinois, through March 31, 2027; and Task Order 1, a $2.3 million cost-plus-fixed-fee order for study planning and preparation awarded June 4, 2018, performed in Oakland, California, completing October 13, 2021.

Task orders

Transactions

Action Obligated Date
Other Administrative Action P00004 · EO14398 a new prospective U.S. Cohort set within the health care system institutions to study cancer $0
Other Administrative Action P00003 $0
Other Administrative Action P00002 $0
Other Administrative Action P00001 $0
Original award $0

Quick answers

Who was awarded contract 75N91018D00021?

75N91018D00021 was awarded to Kaiser Foundation Hospitals by National Cancer Institute (National Institutes of Health) on June 4, 2018.

How much is contract 75N91018D00021 worth?

Orders under 75N91018D00021 have obligated $33,006,267. Their combined current value, with exercised options, is $40,031,858. Their combined potential value, with all options, is $43,983,746. 75N91018D00021's own ceiling is $150,000,000.

How many orders have been placed under contract 75N91018D00021?

8 orders have been placed under 75N91018D00021, the latest on September 20, 2024.

Who can order from contract 75N91018D00021?

75N91018D00021 is a multiple award indefinite delivery contract. Only the awarding agency can place orders on it.

Is contract 75N91018D00021 part of a contract vehicle?

Yes. 75N91018D00021 is part of Cancer Study Cohort Recruitment.

Was contract 75N91018D00021 competed?

The extent of competition for 75N91018D00021 was full and open competition. The government received 4 offers.

On GovTribe

See this IDV's full record

  • Every order and transaction
  • The awardee's other awards and teaming partners
  • Similar IDVs and recompete opportunities
  • Ask GovTribe AI about this IDV